Provided by Tiger Fintech (Singapore) Pte. Ltd.

Roivant Sciences Ltd.

10.64
-0.3900-3.54%
Post-market: 10.51-0.1267-1.19%19:47 EDT
Volume:6.74M
Turnover:73.01M
Market Cap:7.59B
PE:-68.35
High:11.17
Open:11.04
Low:10.62
Close:11.03
Loading ...
Jun 28, 2022

Major Issues Report

8-K - Current report
Jun 28, 2022

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Jun 28, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
May 24, 2022

Major Issues Report

8-K - Current report
Mar 31, 2022

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Mar 30, 2022

Major Issues Report

8-K - Current report
Mar 28, 2022

Correspondence

CORRESP [Cover] - Correspondence
Feb 28, 2022

Correspondence

CORRESP [Cover] - Correspondence
Feb 28, 2022

Major Issues Report

8-K - Current report
Feb 24, 2022

Correspondence

CORRESP [Cover] - Correspondence
Feb 17, 2022

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Feb 14, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 30, 2021

Correspondence

CORRESP [Cover] - Correspondence